Concurrent hyperdiploid acute myeloid leukemia and trisomy 12+ chronic lymphocytic leukemia
- PMID: 39415935
- PMCID: PMC11474343
- DOI: 10.1002/jha2.1009
Concurrent hyperdiploid acute myeloid leukemia and trisomy 12+ chronic lymphocytic leukemia
Keywords: AML; CLL; hyperdiploidy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Chilton L, Hills RK, Harrison CJ, Burnett AK, Grimwade D, Moorman AV. Hyperdiploidy with 49–65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome. Leukemia. 2014;28(2):321–8. - PubMed
-
- Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–77. - PubMed
-
- Abaza Y, Cortes J, Ravandi F, Kadia T, Garcia‐Manero G, Pemmaraju N, et al. Prognostic significance of hyperdiploidy in adult acute myeloid leukemia. Am J Hematol. 2018;93(11):E357–60. - PubMed
LinkOut - more resources
Full Text Sources